Pharmtech Focus: Eyevensys Raises $12M in a Series B Plus Funding Round
Pharmtech Focus: Eyevensys Raises $12M in a Series B Plus Funding Round
Pharmtech Focus: Eyevensys Raises $12M in a Series B Plus Funding Roundhttps://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg150150EyevensysEyevensyshttps://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg
The $12M raised in a Series B Plus funding round will support development of Eyevensys’s EYS809 program for the treatment of wet age-related macular degeneration (AMD), a chronic eye disorder that causes blurred vision or a blind spot in the eye.